Publications

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This document works to assist those managing aid workers who are departing from or returning to Australia from an area affected by a listed human disease.

This document is to describe actions and measures recommended to protect healthcare workers (HCWs) and others who may come in contact with Ebola virus, or patients with suspected or confirmed Ebola virus disease (EVD).

This fact sheet is information for front line health professionals about the possibility of Ebola.

Nếu quý vị nhận được chẩn đoán bị bệnh đường hô hấp nghề nghiệp, bác sĩ có thể báo cáo thông tin của quý vị với sổ bộ đăng ký này. Tìm hiểu khi nào bác sĩ của quý vị phải báo cáo với sổ bộ đăng ký và những thông tin quý vị cần cung cấp.

如果您被诊断患有职业性呼吸系统疾病，您的医生可能会将您的信息报告至登记系统。您可以了解医生在何种情况下必须上报信息，以及您需要提供哪些资料。

ਜੇ ਤੁਹਾਡੇ ਵਿੱਚ ਕਿਸੇ ਕਿੱਤਾਕਾਰੀ ਸਾਹ ਦੀ ਬਿਮਾਰੀ ਦੀ ਪਛਾਣ ਕੀਤੀ ਜਾਂਦੀ ਹੈ, ਤਾਂ ਤੁਹਾਡਾ ਡਾਕਟਰ ਤੁਹਾਡੀ ਜਾਣਕਾਰੀ ਦੀ ਰਿਪੋਰਟ ਰਜਿਸਟਰੀ ਨੂੰ ਕਰ ਸਕਦਾ ਹੈ। ਪਤਾ ਕਰੋ ਕਿ ਤੁਹਾਡੇ ਡਾਕਟਰ ਨੂੰ ਰਜਿਸਟਰੀ ਨੂੰ ਕਦੋਂ ਰਿਪੋਰਟ ਕਰਨੀ ਚਾਹੀਦੀ ਹੈ ਅਤੇ ਤੁਹਾਨੂੰ ਕਿਹੜੀ ਜਾਣਕਾਰੀ ਪ੍ਰਦਾਨ ਕਰਨ ਦੀ ਲੋੜ ਹੈ।

यदि तपाईंलाई व्यावसायिक श्वासप्रश्वास सम्बन्धी रोग भएको निदान गरिन्छ भने, तपाईंको चिकित्सकले तपाईंको जानकारी दर्ता प्रणालीमा रिपोर्ट गर्न सक्छन्। तपाईंको चिकित्सकले कहिले दर्ता प्रणालीमा रिपोर्ट गर्नुपर्छ र तपाईंले कस्तो जानकारी प्रदान गर्नुपर्छ भनेर पत्ता लगाउनुहोस्।

Se hai ricevuto una diagnosi di malattia respiratoria professionale, il tuo medico potrebbe trasmettere le tue informazioni al Registro. Fatti dire quando il tuo medico deve informare il Registro e che tipo di informazione devi fornire.

إذا تم تشخيصك بمرض تنفسي مهني، فقد يقوم طبيبك بإبلاغ معلوماتك إلى السجل. اعرف متى يجب على طبيبك تقديم تقرير إلى السجل وما هي المعلومات التي تحتاج إلى تقديمها

This document contains details of the process for making a change to the National Notifiable Diseases List in Australia.

This document from the Australian and state and territory governments outlines their commitment to reducing incidences of silicosis and other dust diseases among workers, and increase the quality of life for people affected and their families.

Guidelines for health professionals that outline the therapeutic options for the management of human monkeypox (mpox) virus infection and vaccine related complications.

This plan is the first Australian Response Plan for Japanese encephalitis. It provides a framework for nationally co-operative response arrangements for managing Japanese encephalitis virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 27 October 2025 to 9 November 2025.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 13 October 2025 to 26 October 2025.

This report provides advice to the Australian Government on HIV prevention, testing, treatment, awareness raising, decriminalisation, destigmatisation and partnership.

This document contains the process for developing and reviewing the Public Health Laboratory Network (PHLN) laboratory case definitions.

This document contains the work plan and terms of reference for the Public Health Laboratory Network for the period 2019 to 2023.

This Communicable Diseases Network Australia (CDNA) fact sheet gives information health care workers in line with the Australian National Guidelines for the Management of Healthcare Workers Living with Blood Borne Viruses (BBV) and who Perform Exposure Prone Procedures at Risk of Exposure to BBVs.

This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 3 May 2023.

This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 29 June 2023.

This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 11 August 2023.

This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 20 October 2023.